Marca Nominativa depositada no INPI em 15/07/2020 por MABLINK BIOSCIENCE, processo nº 501564637, nas classes 01, 05. Registro em vigor até 15/07/2030.
| Número do processo | 501564637 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 15/07/2020 |
| Data da concessão | 01/02/2022 |
| Vigência até | 15/07/2030 |
| Titular | MABLINK BIOSCIENCE |
| CNPJ/CPF do titular | — |
| UF · País | — · FR |
Chemical, biochemical, biological and biotechnological preparations for scientific use; chemical substances for manufacturing pharmaceutical products; chemical substances for connecting molecules, in particular chemical substances for linking molecules for cancer therapy, for research into active ingredients and medicines; chemical substances for forming antibody conjugates; chemical reagents for scientific purposes other than for medical or veterinary use; reagents for scientific or medical research; chemical, biochemical and biological reagents and especially a technological platform in the form of or used for creating or improving antibody drug conjugates or any protein combined with a medicine, a polynucleotide, another protein, a chemical entity or another functional entity for industry and the sciences; chemical products for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary use; antibodies for scientific or medical research; molecules and biomolecules, especially reagents, antibody fragments, antibodies, all for use in fundamental research and development, medical research as well as scientific diagnosis; diagnostic products for scientific use or for research in connection with antibody conjugates (medicines).;
Pharmaceutical preparations; pharmaceutical products especially for the prevention or treatment of human diseases; chemical, biological and biochemical products for medical and pharmaceutical use, especially, antibody drug conjugates or any protein combined with a medicine, a polynucleotide, another protein, a chemical entity, or another functional entity or these products used as binders or payload molecules; pharmaceutical preparations especially bioconjugates for use in diagnosis and for the treatment of diseases; antibody products, especially, antibody or protein bioconjugates for use in medical diagnosis and the treatment of diseases including antibody/protein drug conjugates, antibody/protein labelled conjugates and antibody/protein imaging agent conjugates; antibody administration devices (medical and pharmaceutical preparations); molecules and biomolecules, especially, reagents, antibody fragments, antibodies, all for use in medical diagnosis and the treatment of disease; pharmaceutical products, medical preparations and products, especially antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; chemical reagents for functionalizing biomolecules for medical use.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501564637 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.